Company Overview
| Stock Name | JW Therap-B |
| Stock Code | 02126 |
| Company Full Name | To be extracted |
| Industry | 醫療保健 |
| Principal Activities | 主要從事抗癌藥的研發、制造及商業化。 |
| Listing Date | 2020-11-03 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國上海市自由貿易試驗區美盛路225號42號樓4樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.jwtherapeutics.com/ |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism |
To be extracted
|
| Offer Price | HK$ 23.80 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 50.0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 1,162,534,800 |
Stock Connect Inclusion
| 26Q2 Regular Review |
| Inclusion Pathway |
None |
| Est. Threshold |
--- |
| Analysis Result |
无法确定入通路径 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 22.0 |
| First Day Open | HK$ 24.35 |
| First Day Change | -7.56% |
| First Day Volume | 48183900.0 |
| First Day Turnover | 1139990000.0 |
Use of Proceeds
| Use of Proceeds | 1、約878.7百萬港元(占所得款項凈額約40.0%)預期將用于我們的核心候選產品relma-cel;
2、約746.9百萬港元(占所得款項凈額的34.0%)預期將用于其他侯選產品;
3、約351.5百萬港元(占所得款項凈額的16.0%)預期將用于潛在管線產品;
4、約219.7百萬港元(占所得款項凈額的10.0%)預期將用于營運資金及一般公司用途。 |
Underwriting Syndicate
Overall Coordinators (4)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536
UBS Securities Hong Kong Limited CE BIN466
China International Capital Corporation Hong Kong Securities Limited CE AEN894
CLSA Limited CE AAB893
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
| 1 |
Aranda Investments Pte. Ltd. |
38,746,400 HKD |
— |
1.67% |
— |
6 months |
2021-05-03 |
| 2 |
AVICT Global Holdings Limited |
116,239,200 HKD |
— |
5.00% |
— |
6 months |
2021-05-03 |
| 3 |
Hillhouse Funds |
77,492,800 HKD |
— |
3.33% |
— |
6 months |
2021-05-03 |
| 4 |
LVC Mi Holding Limited |
77,492,800 HKD |
— |
3.33% |
— |
6 months |
2021-05-03 |
| 5 |
Oaktree Funds |
154,997,500 HKD |
— |
6.67% |
— |
6 months |
2021-05-03 |
| 6 |
Platinum Investment Management Limited |
154,997,500 HKD |
— |
6.67% |
— |
6 months |
2021-05-03 |
| 7 |
Rock Springs Capital Master Fund LP |
154,997,500 HKD |
— |
6.67% |
— |
6 months |
2021-05-03 |
| 8 |
RWC Asset Advisors (US) LLC |
154,997,500 HKD |
— |
6.67% |
— |
6 months |
2021-05-03 |
| 9 |
Veritas Asset Management LLP |
154,997,500 HKD |
— |
6.67% |
— |
6 months |
2021-05-03 |
| 10 |
太平资产管理(香港)有限公司 |
77,492,800 HKD |
— |
3.33% |
— |
6 months |
2021-05-03 |
Directors & Management
| Chairman | 劉誠 |
| Company Secretary | 吳嘉雯 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 百時美施貴寶公司(17.10%) |
// About this page //
This page shows JW Therap-B (02126) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements.
Disclaimer
Site Nature: This website (cibo.hk) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.